Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of colesevelam HCl on hepatic insulin sensitivity, gluconeogenesis, glucose absorption and lipid synthesis in subjects with type 2 diabetes mellitus.

Trial Profile

Effects of colesevelam HCl on hepatic insulin sensitivity, gluconeogenesis, glucose absorption and lipid synthesis in subjects with type 2 diabetes mellitus.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2012

At a glance

  • Drugs Colesevelam (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 02 Dec 2011 Results published in Diabetologia.
    • 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top